| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/21/2009 | CN100454001C Optical system of spectrophotometer of full-automatic biochemical analyzer |
| 01/21/2009 | CN100453651C Pyrophosphoric acid detection sensor, method of detecting nucleic acid and method of discriminating base variety |
| 01/21/2009 | CN100453547C Inhibitors |
| 01/21/2009 | CN100453182C Microstructured separation device, and method for separating liquid components from a liquid containing particles |
| 01/21/2009 | CN100453042C Body fluid testing device |
| 01/20/2009 | US7480053 Position detection based on two-directional correlation |
| 01/20/2009 | US7480032 Device and method for in vitro determination of analyte concentrations within body fluids |
| 01/20/2009 | US7479789 Method and device for measuring the degree of fiber concentration |
| 01/20/2009 | US7479579 Genetically engineered rodent comprisingamyloid precursor protein mutation for use as tool in screening therapeutic agents for treatment of neurodegenerative diseases |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479554 AAV5 nucleic acids |
| 01/20/2009 | US7479546 Pro104 antibody compositions and methods of use |
| 01/20/2009 | US7479545 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
| 01/20/2009 | US7479544 biological conjugated drug binding with a detectable label, or toxin maytansine and calicheamicin; monoclonal antibody as antiinflammatory agents in the therapeutic treatment and diagnostic detection of immune disorders in mammals; biodrugs |
| 01/20/2009 | US7479543 chimeric antibodies comprising variable domain peptides, DNA codes for the antibodies, expression vectors, host cells and a process of culturing the host cells to produce the monoclonal antibodies, used for immunotherapy; nonimmunogenic |
| 01/20/2009 | US7479541 and fusion proteins with green fluorescent protein, used for modulating cell differentiation and apoptosis, including cell formation of tissues |
| 01/20/2009 | US7479538 Improved in vitro binding affinity for HIV-1 gp 120 and gp 41, and human CD4 cells |
| 01/20/2009 | US7479537 Reagents and methods useful for detecting diseases of the breast |
| 01/20/2009 | US7479484 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 01/20/2009 | US7479393 Analytical test element and method for blood analyses |
| 01/20/2009 | US7479392 Quantitative analysis of a biological sample of unknown quantity |
| 01/20/2009 | US7479386 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 01/20/2009 | US7479382 Vectors, host cells; use screening for nematocides; environmentally safe, target-specific ways of controlling plant parasitic nematodes |
| 01/20/2009 | US7479377 Genetic construct intracellular monitoring system |
| 01/20/2009 | US7479376 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 01/20/2009 | US7479375 Using hemocyte preparation, for example, Limulus amebocyte lysate, for detecting in single assay presence of Gramnegative, Grampositive bacterium, and fungus; exploits differential reactivity of Gramnegative, Grampositive bacteria, and fungi with hemocyte to produce measureable change in optical property |
| 01/20/2009 | US7479374 Triacylglycerol-deficient fission yeast and its uses |
| 01/20/2009 | US7479373 Method for identifying compounds modulating taste transduction |
| 01/20/2009 | US7479372 Beta-secretase substrates and uses thereof |
| 01/20/2009 | US7479371 quantifying stem cell growth factor (SCGF); two different anti-SCGF antibodies are used in the sandwich assay, wherein the two different anti-SCGF antibodies react with different epitopes of stem cell growth factor; acute lymphocytic leukemia; acute myeloid leukemia; chronic myeloid leukemia |
| 01/20/2009 | US7479280 Papilloma virus capsid support comprising chimeric lymphocyte epitope for use in identifying modulators to treat and prevention cell proiferative, autoimmune and viral diseases |
| 01/20/2009 | US7479270 Methods and compositions for activating VEGF-D and VEGF-C |
| 01/20/2009 | US7479256 Device that simultaneously and accurately applies microdroplets to a substrate in a regular pattern; a pressure chamber is filled with a buffer medium arranged so that medium can simultaneously be used for applying pressure to the liquid-column ends that are spaced apart from the nozzle orifices |
| 01/20/2009 | US7479255 Hydrogen sensor such as for fuel cell; includes a water-repelling filter covering the gas intake for use in high humidity environments; difference in electrical resistance between the sensing and temperature-compensating elements by using heat of combustion generated from gas and catalyst |
| 01/20/2009 | US7479254 Kit including a cucurbit(6-10)uril derivative bound to a first material; anda second component that is a ligand that non-covalently binds to the cucurbituril bound to a second material; materials include biomolecules, drugs, catalysts, chromophores, fluorescent materials, phosphors, and cyclophanes |
| 01/20/2009 | US7479253 Method of assembling a diagnostic test strip having a functional overlay |
| 01/20/2009 | US7479197 Thin-layer cell |
| 01/20/2009 | US7478627 Fuel control apparatus for internal combustion engine |
| 01/20/2009 | CA2517245C Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 01/20/2009 | CA2380657C Disposable test vial with sample delivery device |
| 01/20/2009 | CA2325633C Steroidal sapogenins and their derivatives for treating alzheimer's disease |
| 01/20/2009 | CA2321030C Sensor for application in molten metals |
| 01/20/2009 | CA2306795C Acetic acid as contrast agent in fluorescence spectroscopy |
| 01/20/2009 | CA2295617C Method, composition and device for the determination of free halogens in aqueous fluids |
| 01/20/2009 | CA2264570C Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer |
| 01/20/2009 | CA2237343C Use of nuclear magnetic resonance to identify ligands to target biomolecules |
| 01/20/2009 | CA2137822C Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 01/20/2009 | CA2108473C Heregulins (hrgs) binding proteins of p185erb2 |
| 01/19/2009 | CA2637997A1 Cm sensor with covalently bound enzyme |
| 01/19/2009 | CA2605130A1 Vaccine composition and uses thereof |
| 01/15/2009 | WO2009009779A2 Automated bone marrow cellularity determination |
| 01/15/2009 | WO2009009718A1 Methods of identifying modulators of ion channels |
| 01/15/2009 | WO2009009662A1 Method of predicting non-response to first line chemotherapy |
| 01/15/2009 | WO2009009613A2 Novel ion channel-forming peptides |
| 01/15/2009 | WO2009009424A2 Rapid generation of t cell-independent antibody responses to t cell-dependent antigens |
| 01/15/2009 | WO2009009408A2 Devices and methods for the detection of analytes |
| 01/15/2009 | WO2009009346A1 A method and composition for simultaneously performing a multiplexed microparticle-based assay for antibody detection |
| 01/15/2009 | WO2009009173A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/15/2009 | WO2009009162A2 Method for determining the effectiveness of stabilized chlorine dioxide in a mouth rinse |
| 01/15/2009 | WO2009009019A2 Treatment and diagnostic methods for fibrosis related disorders |
| 01/15/2009 | WO2009009016A1 Combination anti-cancer therapy |
| 01/15/2009 | WO2009008915A2 Tunable bio-functionalized nanoelectromechanical systems having superhydrophobic surfaces for use in fluids |
| 01/15/2009 | WO2009008908A2 Structure-activity relationships |
| 01/15/2009 | WO2009008729A1 Measuring of fuel composition by using laser |
| 01/15/2009 | WO2009008719A2 Treatment and prevention of inflammatory diseases and autoimmune diseases |
| 01/15/2009 | WO2009008545A1 Magnetic detection element and detection method |
| 01/15/2009 | WO2009008533A1 Magnetic detection element and detecting method |
| 01/15/2009 | WO2009008529A1 Antibody binding specifically to tdp-43 aggregate |
| 01/15/2009 | WO2009008511A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same |
| 01/15/2009 | WO2009008414A1 Monoclonal antibody having neutralizing activity against mmp13 |
| 01/15/2009 | WO2009008358A1 Specimen container |
| 01/15/2009 | WO2009007980A1 Nucleic acid construct systems capable of diagnosing or treating a cell state |
| 01/15/2009 | WO2009007913A2 Protein labelling with tags comprising isotope-coded sub-tags and isobaric sub-tags |
| 01/15/2009 | WO2009007911A2 Melt separation apparatus and method for assaying mineral ore samples using the same |
| 01/15/2009 | WO2009007875A2 Photo acoustic sample detector with light guide |
| 01/15/2009 | WO2009007858A2 Method for detecting and quantifying analytes on a solid support with liposome-encapsulated fluorescent molecules |
| 01/15/2009 | WO2009007842A1 Breath alcohol concentration detector |
| 01/15/2009 | WO2009007676A2 Biomolecule binding ligands |
| 01/15/2009 | WO2009007649A2 Device and method for identifying and determining blood groups |
| 01/15/2009 | WO2009007618A2 Tumour-cell-fixing cells |
| 01/15/2009 | WO2009007463A1 Ultrasound elution of biological ligands |
| 01/15/2009 | WO2009007434A1 Antigen exposing micelle and unordered aggregate |
| 01/15/2009 | WO2009007412A2 Age deglycation |
| 01/15/2009 | WO2009007411A2 Inhibition of age formation |
| 01/15/2009 | WO2009007269A1 Optoelectronic device for measuring the hydration of a plant in its natural environment |
| 01/15/2009 | WO2009007222A1 An antibody specific for the tn antigen for the treatment of cancer |
| 01/15/2009 | WO2009007080A1 Method of preventing and treating acute brain pathologies |
| 01/15/2009 | WO2009007051A2 Method for determining von willebrand factor activity in the absence of ristocetin and for determining the adamts-13 protease |
| 01/15/2009 | WO2009007042A2 Device for providing gases, in particular for isotopic ratio analysis |
| 01/15/2009 | WO2009006990A2 Minor splicosome assay system for modulating cell division |
| 01/15/2009 | WO2009006748A2 Method and system to detect neointima coverage of a stent |
| 01/15/2009 | WO2009006739A1 Systems and methods for enhancing fluorescent detection of target molecules in a test sample |
| 01/15/2009 | WO2009006660A1 Plasma filtration |
| 01/15/2009 | WO2009006659A1 Method for determining thrombogenic microparticles |
| 01/15/2009 | WO2009006657A1 Apparatus for monitoring water for microbial germs |
| 01/15/2009 | WO2008147382A8 Integrated microfluidic assay devices and methods |
| 01/15/2009 | WO2008140774A3 Methods for diagnosing and treating prostate and lung cancer |
| 01/15/2009 | WO2008140592A3 Radioactively labeled 1,4-benzothiazepines and methods of screening for compounds that bind ryanodine receptors |
| 01/15/2009 | WO2008140415A9 H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance |
| 01/15/2009 | WO2008139375A3 Chemical sensor comprising a gel and a fluorescer |